[Federal Register Volume 67, Number 212 (Friday, November 1, 2002)]
[Notices]
[Page 66646]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-27884]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Women's Health Initiative Subcommittee of the Advisory Committee
for Reproductive Health Drugs; Notice of Postponement of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is postponing the
meeting of the Women's Health Initiative Subcommittee of the Advisory
Committee for Reproductive Health Drugs scheduled for November 12 and
13, 2002. The meeting was announced in the Federal Register of October
21, 2002 (67 FR 64651). FDA's Center for Drug Evaluation and Research
is going to evaluate additional data relevant to the topic. Future
meeting dates will be announced in the Federal Register.
FOR FURTHER INFORMATION CONTACT: Jayne E. Peterson, Center for Drug
Evaluation and Research (HFD-21), Food and Drug Administration, 5600
Fishers Lane, Rockville, MD 20857, 301-827-7001, FAX 301-827-6776, or
e-mail: [email protected], or FDA Advisory Committee Information
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code
12537. Please call the Information Line for up-to-date information on
this meeting.
Dated: October 24, 2002.
LaJuana D. Caldwell,
Acting Senior Associate Commissioner for External Relations.
[FR Doc. 02-27884 Filed 10-31-02; 8:45 am]
BILLING CODE 4160-01-S